Zhonghong Healthcare: 2024 Semi-Annual Report Summary
Zhonghong Healthcare: 2024 Semi-Annual Report
Zhonghong Medical (300981.SZ): a net loss of 325.299 million yuan in the first half of the year, turning around year-on-year.
On August 29, Gelonghui announced the semi-annual report for the first half of 2024, with revenue of 1.148 billion yuan, a year-on-year increase of 14.97%; net income attributable to shareholders of the listed company was 32.5299 million yuan, turning loss into profit year-on-year; net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was -4.2721 million yuan; basic earnings per share was 0.0836 yuan.
China Red Medical (300981.SZ) released its performance for the first half of the year, turning losses into profits of 32.5299 million yuan.
Zhonghong Medical (300981.SZ) released its semi-annual report for 2024, with the company's revenue reaching 11.48...
Here's Why Zhonghong Pulin Medical Products (SZSE:300981) Can Manage Its Debt Despite Losing Money
China Red Medical (300981.SZ): The main customers of the Safety Infusion Division products are currently in the domestic market.
On July 30th, gelunhui, 中红医疗(300981.SZ), stated on the investor interaction platform that the company's safety infusion business unit mainly serves the domestic market, and is not greatly affected by the above-mentioned additional tariffs. The main measures taken by the company regarding rubber glove tariffs include: 1. Expanding markets - actively exploring non-U.S. markets, improving market share in other regions. Marketing methods are used to promote the independent brand, vigorously expand the domestic market, and diversify market risks; 2. Reducing costs, promoting digital construction, reducing energ 南湖区南都村卫生室y consumption, and strengthening cost advantages; 3.布.
China Red Medical (300981.SZ): Kolon Medical Instruments obtains the registration certificate for one-time use venous indwelling needle medical instruments.
China Red Medical (300981.SZ) announced that its subsidiary, Jiangxi Kailuan Medical Instrument Manufacturing Co., Ltd. (hereinafter referred to as "...")
Zhonghong Medical (300981.SZ) plans to distribute 5 yuan per 10 shares on June 27th, ex-right and ex-dividend.
Zhonghong Medical (300981.SZ) announced that its annual equity distribution plan for 2023 is to distribute RMB 5.00 in cash (including tax) per 10 shares to all shareholders. The ex-rights and ex-dividend date is June 27, 2024.
Zhonghong Medical (300981.SZ): share buyback completed, a total of 8,426,000 shares were repurchased with a total expenditure of 10,025,900 yuan.
On June 14th, Gelonhui reported that Zhonghong Medical (300981.SZ) announced that the actual repurchase period of the company was from March 15, 2024 to June 13, 2024. The company used its own funds through a repurchase special securities account to accumulate repurchased shares in a centralized bidding method, with a total quantity of 842,555 shares, accounting for 0.2160% of the total share capital of the company. The highest fill price was 13.00 yuan/share, the lowest fill price was 10.35 yuan/share, and the total amount paid was 10.0259 million yuan (excluding trading fees). As of the disclosure date of the announcement, the company's share repurchase plan for this time has been fully implemented.
Returns On Capital Signal Tricky Times Ahead For Zhonghong Pulin Medical Products (SZSE:300981)
Zhonghong Healthcare (300981.SZ) announced its 2023 annual results, with a net loss of 131 million yuan, a year-on-year profit to loss
Zhonghong Healthcare (300981.SZ) released the 2023 annual results report. The company achieved operating income during the reporting period...
Zhonghong Healthcare (300981.SZ): First repurchase of 290,000 shares on March 15
Gelonghui, March 18, 丨 Zhonghui Healthcare (300981.SZ) announced that on March 15, 2024, the company implemented the first repurchase through a dedicated securities account. The number of shares repurchased was 290,000 shares, accounting for 0.0744% of the company's total share capital (not excluding the number of shares in the previous repurchased special account). The maximum transaction price was 11.78 yuan/share, and the minimum transaction price was 11.67 yuan/share. The total amount paid was RMB 340.0826 million (excluding transaction fees).
Is Zhonghong Pulin Medical Products (SZSE:300981) Using Debt Sensibly?
Zhonghong Healthcare (300981.SZ): Plans to spend 6.658.05 million yuan to repurchase shares
Gelonghui, Feb. 27丨Zhonghui Healthcare (300981.SZ) announced that from January 12, 2024 to February 8, 2024, the closing price of Zhonghong Pulin Medical Products Co., Ltd. (“Company”) stock closing price has fallen below 15.1,519 yuan/share for 20 consecutive trading days. According to the company's “Plan to stabilize the company's stock price within three years after stock listing”, the conditions for triggering measures to stabilize stock prices have been met. In order to fulfill the promise of stable stock prices, and based on judgment of the company's value and confidence in future development, it is planned to use its own capital to concentrate on competition, taking into account factors such as the company's business situation and financial situation
Zhonghong Healthcare (300981.SZ): Conditions for triggering measures to stabilize stock prices
Gelonghui, Feb. 8, 丨 Zhonghui Healthcare (300981.SZ) announced that according to the starting conditions in the company's share price stabilization commitment, if the closing price of the company's stock price for 20 consecutive trading days falls below the company's audited net assets per share at the end of the previous fiscal year (net assets per share = total equity of common shareholders attributable to the parent company in consolidated financial statements/total company shares at the end of the year), some or all measures will be taken to stabilize the company's stock price in the order of the company's shares repurchased, controlling shareholders' holdings increased, and directors and senior management increased their holdings. According to the “Plan for Stabilizing the Company's Stock Price Within Three Years After the Company's Stock Listing
Investors Don't See Light At End Of Zhonghong Pulin Medical Products Co., Ltd.'s (SZSE:300981) Tunnel
Zhonghong Healthcare (300981.SZ) appointed Yang Hao as the company's general manager
Zhonghong Medical (300981.SZ) announced that the board of directors of the company recently received a written statement from Chen Jun, general manager of the company...
Zhonghong Healthcare (300981.SZ) completed the repurchase of 593,600 shares at a cost of 8.9557 million yuan
Zhonghong Medical (300981.SZ) announced that the actual repurchase period for the company is October 9 to 2, 2023...
Zhonghong Healthcare (300981.SZ): The capacity utilization rate of the company's condom production line is at a high level this year, and the operating status is progressing steadily
Gelonghui, December 27丨Zhonghong Healthcare (300981.SZ) said on the investor interactive platform on December 27 that the capacity utilization rate of the company's condom production line is at a high level this year, and the operating status is progressing steadily. The company has more than 100 types of condoms, of which the company's unique products are profitable. In particular, with breakthroughs in polyurethane kettling technology, the cost of the company's polyurethane condoms was clearly optimized, further improving the profit margin of the company's related products. Variety diversity is one of the company's major advantages. It can meet the needs of different customers. The company will gradually optimize the product structure and increase high-margin products when conditions permit
Zhonghong Medical (300981.SZ): There are already some orders for polyisoprene gloves
Gelonghui November 21丨Zhonghong Medical (300981.SZ) said at an investor relations event that there are already some orders for polyisoprene gloves, and some dealers have submitted requests to send samples, so it is expected that related businesses will have a lot of room for expansion.
No Data
No Data